Andy holds a Pharmacology degree from the University of Leeds (UK), where his final year focused on data mining the human genome for undiscovered inwardly rectifying potassium channels. This sparked Andy’s passion for using software to tackle data challenges in drug development. For over twenty years, Andy has worked at software companies, delivering solutions that support global Clinical Operations, Clinical Data Management, and Pharmacovigilance processes. Andy joined CluePoints in December 2022 and serves as CEO.
